158 related articles for article (PubMed ID: 11553625)
1. Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis.
Gensure RC; Carter PH; Petroni BD; Jüppner H; Gardella TJ
J Biol Chem; 2001 Nov; 276(46):42692-9. PubMed ID: 11553625
[TBL] [Abstract][Full Text] [Related]
2. Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1--36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking.
Gensure RC; Gardella TJ; Jüppner H
J Biol Chem; 2001 Aug; 276(31):28650-8. PubMed ID: 11356832
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor.
Behar V; Bisello A; Bitan G; Rosenblatt M; Chorev M
J Biol Chem; 2000 Jan; 275(1):9-17. PubMed ID: 10617579
[TBL] [Abstract][Full Text] [Related]
4. Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations.
Carter PH; Petroni BD; Gensure RC; Schipani E; Potts JT; Gardella TJ
Endocrinology; 2001 Apr; 142(4):1534-45. PubMed ID: 11250934
[TBL] [Abstract][Full Text] [Related]
5. Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor.
Gensure RC; Shimizu N; Tsang J; Gardella TJ
Mol Endocrinol; 2003 Dec; 17(12):2647-58. PubMed ID: 12947048
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies.
Mannstadt M; Luck MD; Gardella TJ; Jüppner H
J Biol Chem; 1998 Jul; 273(27):16890-6. PubMed ID: 9642250
[TBL] [Abstract][Full Text] [Related]
7. Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor.
Shimizu M; Potts JT; Gardella TJ
J Biol Chem; 2000 Jul; 275(29):21836-43. PubMed ID: 10777513
[TBL] [Abstract][Full Text] [Related]
8. Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide.
Bergwitz C; Jusseaume SA; Luck MD; Jüppner H; Gardella TJ
J Biol Chem; 1997 Nov; 272(46):28861-8. PubMed ID: 9360953
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.
Gardella TJ; Luck MD; Jensen GS; Schipani E; Potts JT; Jüppner H
Endocrinology; 1996 Sep; 137(9):3936-41. PubMed ID: 8756569
[TBL] [Abstract][Full Text] [Related]
10. Studies of the N-terminal region of a parathyroid hormone-related peptide (1-36) analog: receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents.
Carter PH; Jüppner H; Gardella TJ
Endocrinology; 1999 Nov; 140(11):4972-81. PubMed ID: 10537121
[TBL] [Abstract][Full Text] [Related]
11. Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking.
Behar V; Bisello A; Rosenblatt M; Chorev M
Endocrinology; 1999 Sep; 140(9):4251-61. PubMed ID: 10465299
[TBL] [Abstract][Full Text] [Related]
12. Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist.
Gardella TJ; Luck MD; Jensen GS; Usdin TB; Jüppner H
J Biol Chem; 1996 Aug; 271(33):19888-93. PubMed ID: 8702701
[TBL] [Abstract][Full Text] [Related]
13. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H
N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170
[TBL] [Abstract][Full Text] [Related]
14. Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptor.
Shimizu N; Dean T; Tsang JC; Khatri A; Potts JT; Gardella TJ
J Biol Chem; 2005 Jan; 280(3):1797-807. PubMed ID: 15550385
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.
Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H
Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745
[TBL] [Abstract][Full Text] [Related]
16. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
[TBL] [Abstract][Full Text] [Related]
17. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor.
Bisello A; Greenberg Z; Behar V; Rosenblatt M; Suva LJ; Chorev M
Biochemistry; 1996 Dec; 35(49):15890-5. PubMed ID: 8961954
[TBL] [Abstract][Full Text] [Related]
18. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor.
Greenberg Z; Bisello A; Mierke DF; Rosenblatt M; Chorev M
Biochemistry; 2000 Jul; 39(28):8142-52. PubMed ID: 10889020
[TBL] [Abstract][Full Text] [Related]
19. Receptors for PTH and PTHrP: their biological importance and functional properties.
Mannstadt M; Jüppner H; Gardella TJ
Am J Physiol; 1999 Nov; 277(5):F665-75. PubMed ID: 10564229
[TBL] [Abstract][Full Text] [Related]
20. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
Hoare SR; Usdin TB
J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
